APA (7th ed.) Citation

A, T., N, F., T, V., F, T., S, D., B, R., . . . S, H. (2026). Teclistamab for heavily pretreated relapsed/refractory POEMS syndrome. Haematologica, 111(4), 1490. https://doi.org/10.3324/haematol.2025.287606

Chicago Style (17th ed.) Citation

A, Talbot, et al. "Teclistamab for Heavily Pretreated Relapsed/refractory POEMS Syndrome." Haematologica 111, no. 4 (2026): 1490. https://doi.org/10.3324/haematol.2025.287606.

MLA (9th ed.) Citation

A, Talbot, et al. "Teclistamab for Heavily Pretreated Relapsed/refractory POEMS Syndrome." Haematologica, vol. 111, no. 4, 2026, p. 1490, https://doi.org/10.3324/haematol.2025.287606.

Warning: These citations may not always be 100% accurate.